Public Health Emergency - Leading a Nation Prepared
Antimicrobial resistance presents one of the greatest
modern threats to public health. We need innovative, global, solutions
to address it. Each of the partners has a unique role to play in
bringing new antibiotics through the development pipeline.
CARB-X is possibly the largest public-private partnership in the world dedicated to preclinical antibiotic development. It involves seven partners in the United States and the United Kingdom, and it is backed with half a billion dollars in funding. CARB-X partners are working together to set up a diverse portfolio with more than 20 high-quality antibacterial products.
More Videos >>
Home | Contact Us | Accessibility | Privacy Policies | Disclaimer | HHS Viewers & Players | HHS Plain Language
Assistant Secretary for Preparedness and Response (ASPR), 200 Independence Ave., SW, Washington, DC 20201
U.S. Department of Health and Human Services | USA.gov |
HealthCare.gov in Other Languages